摘要 |
The present invention provides medicinal compositions characterized by comprising as the active ingredient either a compound represented by a formula [I] or a pharmaceutically acceptable composite thereof; [wherein X represents oxygen or sulfur; R<SUB>1 </SUB>represents e.g., C<SUB>1-4 </SUB>alkyl, phenyl optionally substituted, etc.; Q<SUB>1 </SUB>represents spacer consisted of 0 to 3 carbon atoms; R<SUB>2 </SUB>represents, e.g., phenyl optionally substituted; R<SUB>3 </SUB>represents, e.g., hydrogen, C<SUB>1-4 </SUB>alkyl, or a group represented by the following formulae; -CONH-R<SUB>6</SUB>; R<SUB>4 </SUB>and R<SUB>5 </SUB>represent e.g., nitro, cyano, C<SUB>1-4 </SUB>alkylcarbonyl, respectively]; in particular, medicine which is useful as therapeutic and/or protective drugs for inflammatory diseases and/or allergic diseases by improving sick conditions accompanied with the stimulated phospholipase A(2) activity.
|